Teruhiko Tamaya

Teruhiko Tamaya's AcademicInfluence.com Rankings

Teruhiko Tamaya

Medical

#3093

World Rank

#3548

Historical Rank

Gynecology

World Rank

Historical Rank

Oncology

#209

World Rank

#217

Historical Rank

medical Degrees

Download Badge

Medical

Teruhiko Tamaya's Degrees

PhD Medical Science University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Teruhiko Tamaya Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Teruhiko Tamaya's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. (2000) (161)
Outcome of fertility‐preserving treatment in young women with endometrial carcinomas (2005) (133)
Peritoneal Fluid lnterleukin‐1β and Tumor Necrosis Factor in Patients With Benign Gynecologic Disease (1991) (118)
[Angiogenic factors in endometriosis]. (2001) (115)
Steroid receptor levels and histology of endometriosis and adenomyosis. (1979) (114)
Coexpression of Gas6/Axl in Human Ovarian Cancers (2004) (111)
Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. (1996) (102)
In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. (2000) (101)
[A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers]. (1991) (101)
Expression of oestrogen receptor-α and -β in ovarian endometriomata (1999) (101)
Revised Guidelines for Neonatal Screening Programmes for Primary Congenital Hypothyroidism (1999) (100)
Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. (1994) (100)
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. (1998) (99)
Expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis. (1992) (82)
Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. (2000) (80)
Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. (2001) (79)
Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma (1998) (76)
COMPARISON OF CELLULAR LEVELS OF STEROID RECEPTORS IN UTERINE LEIOMYOMA AND MYOMETRIUM (1985) (76)
Evidence for coupling of phosphotyrosine phosphatase to gonadotropin‐releasing hormone receptor in ovarian carcinoma membrane (1996) (73)
Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human Monocytes (1990) (71)
Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance. (1994) (70)
GnRH receptor and apoptotic signaling. (2000) (69)
Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers. (2003) (66)
Non‐steroidal anti‐inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase‐2 protein expression in endometrial cancer cells (2004) (66)
A case-control study of uterine endometrial cancer of pre- and post-menopausal women. (2000) (66)
Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. (1998) (63)
Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers (1999) (62)
Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. (1995) (62)
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers (2008) (61)
Preventive Effects of Isoflavones, Genistein and Daidzein, on Estradiol‐17β‐related Endometrial Carcinogenesis in Mice (2001) (60)
Direct Protection by a Gonadotropin-Releasing Hormone Analog from Doxorubicin-Induced Granulosa Cell Damage (2006) (59)
Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers. (2004) (58)
Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. (2002) (58)
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. (2007) (58)
The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. (2000) (57)
Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers. (1998) (54)
Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: inhibition by plant herb extracts of steroid protein binding in the rabbit. (1986) (54)
Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers. (2002) (54)
Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers (2007) (54)
Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma. (1997) (52)
Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium. (1986) (52)
Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. (1999) (51)
A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. (2000) (51)
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers (2007) (48)
Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. (2006) (48)
Alteration of E-cadherin, α-and β-catenin mRNA expression in human uterine endometrium during the menstrual cycle (1996) (47)
Telomerase activity in the human endometrium throughout the menstrual cycle. (1998) (46)
Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers (1997) (46)
Telomerase activity in the female reproductive tract and neoplasms. (1998) (45)
Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers (2004) (45)
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. (2004) (44)
Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens. (1995) (43)
Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers (2009) (42)
PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway (2002) (42)
Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. (2004) (41)
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers (1999) (41)
Sex hormone-binding globulin mRNA levels in human uterine endometrium. (1994) (41)
Clinical Implications of Expression of ETS-1 Related to Angiogenesis in Metastatic Lesions of Ovarian Cancers (2004) (40)
Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers. (1997) (40)
Estradiol-17β- progesterone and 5α-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject (1979) (40)
Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. (2001) (40)
Expression of IP-10 related to angiogenesis in uterine cervical cancers (2007) (40)
Expression of Progesterone Receptor Form A and B mRNAs in Uterine Leiomyoma (1998) (40)
Dominant Expression of Progesterone Receptor Form B mRNA in Ovarian Endometriosis (1999) (39)
The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects (1994) (39)
Estrogen Receptors in Brain Tumors (1984) (39)
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) related to angiogenesis in ovarian endometriosis. (1999) (38)
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. (1999) (38)
Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle. (1998) (38)
Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers. (1997) (38)
Enhancing Effects of Estrogens on Endometrial Carcinogenesis Initiated by N‐Methyl‐N‐nitrosourea in ICR Mice (1993) (37)
Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and α- and β-catenin mRNA expressions (1996) (37)
Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers (2001) (37)
Gynecologic tumors and symptoms in childhood and adolescence; 10‐years' experience (1994) (37)
Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. (1993) (37)
Augmentation of leptin and hypoxia-inducible factor 1α mRNAs in the pre-eclamptic placenta (2004) (35)
Studies on the pathogenicity of anaerobes, especially Prevotella bivia, in a rat pyometra model. (1998) (35)
Estrogen-related receptor expression in placenta throughout gestation (2005) (35)
Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells. (1998) (35)
Clinical implications of expression of ETS‐1 in relation to angiogenesis in ovarian cancers (2003) (34)
Clinical Implications of the Expression of Estrogen Receptor-α and -β in Primary and Metastatic Lesions of Uterine Endometrial Cancers (2002) (34)
Expression of estrogen receptor α and β in myometrium of premenopausal and postmenopausal women (2003) (34)
Role of protease activated receptor-2 in tumor advancement of ovarian cancers. (2007) (34)
Expression of oestrogen receptor α and β mRNA in corpus luteum of human subjects (1999) (34)
Penetration of Ravuconazole, a New Triazole Antifungal, into Rat Tissues (2002) (34)
Corticosteroid-binding globulin mRNA levels in human uterine endometrium (1994) (34)
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. (2009) (33)
Expression of progesterone receptor isoforms in corpora lutea of human subjects: correlation with serum oestrogen and progesterone concentrations. (1998) (33)
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers. (1998) (33)
Presence of gonadotropin‐releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma (1994) (32)
Acute myelogenous leukemia in pregnancy: Fetal blood sampling and early effects of chemotherapy (1994) (32)
Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. (1995) (32)
Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice. (2001) (32)
Evidence for the Synthesis of Corticosteroid-Binding Globulin in Human Placenta (1999) (32)
Alteration of E-cadherin, alpha- and beta-catenin mRNA expression in human uterine endometrium during the menstrual cycle. (1996) (32)
Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium. (1996) (32)
The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers. (2000) (31)
Effects of Tamoxifen on Endometrial Carcinogenesis in Mice (1998) (31)
Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle. (1996) (31)
Hypokalemia in a pregnant woman with long‐term heavy cola consumption (1994) (31)
Estrogen activates migration potential of endometrial cancer cells through basement membrane. (1996) (31)
Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers. (1999) (31)
Angiogenesis in Endometriosis and Angiogenic Factors (1999) (31)
Expression of estrogen receptor wild type and exon 5 splicing variant mRNAs in normal and endometriotic endometria during the menstrual cycle. (1997) (31)
Expression of PTEN and PTEN pseudogene in endometrial carcinoma. (2000) (31)
The mechanism of action of the copper intrauterine device. (1976) (30)
p53 overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status. (1999) (30)
Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line. (2003) (29)
Genital bleeding in premenarcheal children (1995) (28)
Studies on the clinical implications of anaerobes, especiallyPrevotella bivia, in obstetrics and gynecology (1998) (28)
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in ovarian cancers. (1998) (28)
[An early phase II study of CPT-11 in gynecologic cancers. Research Group of CPT-11 in Gynecologic Cancers]. (1991) (28)
Preterm labor and bacterial intraamniotic infection: arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. (1998) (27)
Comparative Study on the Effectiveness of Antifungal Agents in Different Regimens against Vaginal Candidiasis (1998) (27)
Microbiology of Bartholin's Gland Abscess in Japan (2005) (27)
Leiomyoma of the Fallopian Tube (2000) (26)
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens. (2000) (26)
Danazol binding to steroid receptors in human uterine endometrium. (1984) (25)
Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors. (1997) (25)
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers. (2005) (25)
Elastase activity of anaerobes isolated from amniotic fluid with preterm premature rupture of membranes. (1999) (25)
Expression of sex hormone-binding globulin exon VII splicing variant messenger RNA in human uterine endometrial cancers. (1997) (25)
Preventive Effects of Glycyrrhizae radix Extract on Estrogen‐related Endometrial Carcinogenesis in Mice (1999) (25)
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle. (2003) (24)
Mechanism of antiprogestational action of synthetic steroids. (1978) (24)
Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone. (1994) (24)
Expression of E-cadherin and α- and β-catenin mRNAs in ovarian cancers (1997) (24)
Signal transduction of GnRH receptor in the reproductive tract tumor. (1996) (24)
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. (2005) (24)
Steroid receptors and metastatic potential in endometrial cancers (2000) (24)
Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). (1997) (24)
Vaginal microflora in healthy women with Gardnerella vaginalis (2000) (23)
Preventive effects of glycyrrhizin on estrogen-related endometrial carcinogenesis in mice. (2007) (23)
Identification of various exon-deleted progesterone receptor mRNAs in human endometrium and ovarian endometriosis. (1998) (23)
In vitro stimulation of granulosa cells by a combination of different active ingredients of unkei-to. (2004) (23)
Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers. (1996) (23)
Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis (1999) (23)
Puerperal intrauterine infection caused by Edwardsiella tarda (2003) (23)
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy (2003) (23)
Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. (1997) (22)
Expression of sex hormone-binding globulin mRNA in human ovarian cancers. (1995) (22)
Clinical Significance of Expression of Estrogen Receptor α and β mRNAs in Ovarian Cancers (2000) (22)
Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers. (1995) (22)
Expression of Interferon-Gamma-Inducible Protein 10 Related to Angiogenesis in Uterine Endometrial Cancers (2008) (22)
Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. (2002) (22)
Expression of E-Cadherin and α- and β-Catenin mRNAs in Uterine Cervical Cancers (1997) (22)
Is Extrapituitary Action of Gonadotrophin-Releasing Hormone Biologically Significant? (1992) (21)
Brain metastasis as first manifestation of ovarian cancer. (1999) (21)
Suppression of E-cadherin and alpha- and beta-catenin mRNA expression in the metastatic lesions of gynecological cancers. (1997) (21)
Identification of Exon-Deleted Progesterone Receptor mRNAs in Human Uterine Endometrial Cancers (2000) (21)
Significance of Sex Steroids in Roles of Cadherin Subfamily and Its Related Proteins in the Uterine Endometrium and Placenta (1998) (21)
Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis. (1998) (21)
Estrogen binding sites in peripheral blood monocytes and effects of danazol on their sites in vitro. (1992) (21)
Expression of estrogen receptor exon 5 splicing variant (ER E5SV) mRNA in gynaecological cancers (1997) (21)
Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers. (1998) (20)
Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma. (2003) (20)
Comparative study on vaginal or oral treatment of bacterial vaginosis. (1997) (20)
Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice. (2002) (20)
Metastatic vulvar Paget's disease responding to combination chemotherapy: case report. (1990) (20)
Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas. (1995) (20)
Effects of sex steroids on cell differentiation and interleukin-1 beta production in the human promyelocytic leukemia cell line HL-60. (1992) (20)
Ovarian abscess caused by Peptostreptococcus magnus following transvaginal ultrasound-guided aspiration of ovarian endometrioma and fixation with pure ethanol. (1998) (20)
Expression of E-cadherin, α- and β-catenin mRNAs in ovarian endometriosis (1996) (19)
Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer* (1992) (19)
Sexual dimorphism of binding sites of testosterone and dihydrotestosterone in rabbit model. (1993) (19)
A novel sex-determining region on Y (SRY) nonsense mutation identified in a 45,X/47,XYY female. (1999) (19)
Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus. (2001) (19)
Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases, Axl and Sky, in human uterine endometrium and ovarian endometriosis. (2002) (19)
Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and alpha- and beta-catenin mRNA expressions. (1996) (19)
Bacterial isolates from patients with preterm labor with and without preterm rupture of the fetal membranes. (1999) (19)
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. (2007) (19)
Tight coupling of gonadotropin-releasing hormone receptor to stimulated phosphoinositide turnover and antigonadotropic action in granulosa cells. (1992) (18)
Successful pregnancy in a patient with pseudomyxoma peritonei arising from ovarian mucinous cystadenocarcinoma treated with cisplatin. (1995) (18)
Possible evidence that the herbal medicine shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium. (1995) (18)
Transient fetal blood flow redistribution induced by maternal diabetic ketoacidosis diagnosed by Doppler ultrasonography (2000) (18)
Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects. (1995) (18)
Sex steroid-dependent angiogenesis in uterine endometrial cancers (2005) (18)
Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers. (2006) (17)
Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme. (1997) (17)
Inhibitory Effects of Medroxyprogesterone Acetate on Mouse Endometrial Carcinogenesis (1995) (17)
A novel sex-determining region on Y (SRY) missense mutation identified in a 46,XY female and also in the father. (1999) (17)
Telomerase activity is found in the epithelial cells but not in the stromal cells in human endometrial cell culture. (1998) (17)
Expression of sex hormone-binding globulin mRNA in human endometrial cancers (1995) (17)
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. (2003) (16)
Uterine contractions increase fetal heart preload (2003) (16)
Contribution of functional groups of 19-nor-progestogens to binding to progesterone and estradiol-17beta receptors in rabbit uterus. (1977) (16)
Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers. (2002) (16)
MRI during pregnancy (2003) (16)
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer. (2006) (16)
Estrogen activates invasiveness of endometrial cancel cells to the interstitium. (1995) (16)
Biological implications of estrogen and androgen effects on androgen receptor and its mRNA levels in human uterine endometrium. (1995) (16)
Concentrations of Steroid Receptors in Normal Human Endometrium in Relation to the Day of the Menstrual Cycle (1986) (16)
Estrogen Dependency in Uterine Endometrial Cancers (1998) (16)
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa (1996) (16)
Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells. (1993) (15)
Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause (2003) (15)
Inhibition by plant herb extracts of steroid bindings in uterus, liver and serum of the rabbit (1986) (15)
Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol (1986) (15)
Penetration of Oral Fluconazole into Gynecological Tissues (1999) (15)
Plausible linkage of hypoxia inducible factor‐1α in uterine cervical cancer (2006) (15)
Expression of oestrogen receptor alpha and beta mRNA in corpus luteum of human subjects. (1999) (15)
Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers (2008) (15)
Localization of sex hormone-binding globulin mRNA expression in human uterine endometrium. (1997) (15)
Expression of oestrogen receptor α and β in uterine endometrial and ovarian cancers (2002) (15)
Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review). (2003) (15)
Enhancing effect of ethanol or saké on methylazoxymethanol acetate-initiated large bowel carcinogenesis in ACI/N rats. (1991) (14)
Elevated CA125 serum levels in a patient with tuberculous peritonitis (2006) (14)
Levels of sex hormone-binding globulin and corticosteroid-binding globulin mRNAs in corpus luteum of human subjects: correlation with serum steroid hormone levels. (1999) (14)
Expression of size-polymorphic androgen receptor (AR) gene in ovarian endometriosis according to the number of cytosine, adenine, and guanine (CAG) repeats in AR alleles (1999) (14)
Expression of aberrant estrogen receptor mRNA in endometrial cancers in comparison with normal endometria. (1994) (14)
Acardiac acephalic monster extremely larger than its co-twin. A case report. (1991) (14)
Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report. (1992) (14)
Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis. (1995) (14)
DNA Polymorphism in B-Domain of the Estrogen Receptor-α Among Japanese Women (1998) (14)
Inhibitory effects of Hochu-ekki-to on endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17beta-estradiol in mice. (2006) (14)
Expression of E-cadherin and alpha- and beta-catenin mRNAs in ovarian cancers. (1997) (14)
Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers. (2002) (14)
A dermoid cyst of the paravaginal space (2006) (13)
Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate (1994) (13)
[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion]. (1996) (13)
Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine endometrium (1997) (13)
Phytoestrogens and reproductive biology (2005) (13)
Estrogen and androgen receptors in aorta of the rabbit and regulation by estrogen and androgen. (1993) (13)
Effects of crude herbal ingredients on intrauterine infection in a rat model (1998) (13)
Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice. (2005) (13)
Pharmacokinetics of cephem antibiotics in exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy (1990) (13)
Gi protein-mediated translocation of serine/threonine phosphatase to the plasma membrane and apoptosis of ovarian cancer cell in response to gonadotropin-releasing hormone antagonist cetrorelix (2006) (13)
Phosphotyrosine phosphatase-activity in membranes from endometrial carcinoma. (1995) (12)
Therapeutic effects of a new quinolone, DU-6859a, on polymicrobial infections in a newly designed model of rat uterine endometritis. (1998) (12)
Synergistic effects of danazol and mifepristone on the cytotoxicity of UCN-01 in hormone-responsive breast cancer cells. (2000) (12)
Preventive effects of danazol on endometrial carcinogenesis in mice. (2000) (12)
Effect of Ravuconazole, a New Triazole Antifungal, in a Rat Intraabdominal Abscess Model (2001) (12)
Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells. (1997) (12)
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers (2008) (12)
Expression of Size-Polymorphic Androgen Receptor Gene in Uterine Leiomyoma according to the Number of Cytosine, Adenine, and Guanine Repeats in Androgen Receptor Alleles (1999) (12)
Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17 beta-estradiol. (1995) (12)
Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells. (2001) (12)
Enhancement of growth-promoting activity in extract from uterine cancers by protein kinase C in human endometrial fibroblasts. (1992) (12)
Comparative Study of the Effectiveness of Oral Fluconazole and Intravaginal Clotrimazole in the Treatment of Vaginal Candidiasis (1995) (12)
Endodermal sinus tumor of the vagina in an infant: magnetic resonance imaging evaluation. (1993) (12)
Comparison between transabdominal-vulvar and transvulvar approaches for peritoneal vaginoplasty in patients with congenital absence of the vagina. (1997) (12)
Successful outcomes of pregnancy complicated with dermatomyositis (1992) (12)
Immunohistochemical detection of estrogen and progesterone receptors in spermatozoa of infertile men. (1997) (12)
Bacteriological epidemiology and treatment of bacterial vaginosis. (1996) (11)
Danazol decreases transcription of estrogen receptor gene in human monocytes. (1995) (11)
Characterization of steroid receptors in human ovarian cancer. (2010) (11)
Decrease in interferon-γ production by peripheral blood mononuclear cells in patients with uterine cervical cancer (2004) (11)
Sex steroidal regulation of vessel permeability associated with vessel endothelial cadherin (V-cadherin) (1998) (11)
Adequate Levofloxacin Treatment Schedules for Uterine Cervicitis Caused by Chlamydia trachomatis (2000) (11)
Current Status and Fluconazole Treatment of Pelvic Fungal Gynecological Infections (2000) (11)
Acute pseudo-obstruction of the colon (Ogilvie's syndrome) during pregnancy. (1990) (11)
Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. (2007) (11)
Lower segment uterine rupture related to early pregnancy by in vitro fertilization and embryo transfer after a previous cesarean delivery. (1998) (11)
Chronological observation of mouse endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17 beta-estradiol. (1996) (11)
Serum hormone and steroid hormone receptor levels during luteal-phase and long-term treatment with danazol. (1983) (11)
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers (2009) (10)
Primary adenoid cystic carcinoma of Bartholin's gland. A case report. (1994) (10)
Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions. (2003) (10)
Estrogen induces c-Ha-ras expression via activation of tyrosine kinase in uterine endometrial fibroblasts and cancer cells (1995) (10)
Lack of Evidence for Aromatase Expression in Human Ovarian Epithelial Carcinoma (1994) (10)
Inhibitory Effects of Toremifene on N‐Methyl‐N‐nitrosourea and Estradiol‐17β‐induced Endometrial Carcinogenesis in Mice (2002) (10)
Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers. (1997) (10)
Dominant expression of sex‐hormone‐binding‐globulin exon‐7 splicing variant over wild‐type mRNA in human ovarian cancers (1998) (10)
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-α-related mechanism (2006) (10)
Primary endodermal sinus tumor of the vulva in a 52-year-old woman with long-term survival: a case report. (2007) (10)
Stimulatory effects of estrogen on gonadotropin-releasing hormone-induced phosphoinositide turnover in granulosa cells (1991) (10)
Successful pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report (2004) (10)
Expression of sex hormone-binding globulin exon VII splicing variant messenger ribonucleic acid in human ovarian endometriosis. (1998) (10)
The use of peritoneum for vaginoplasty in 24 patients with congenital absence of the vagina (2006) (10)
Expression of sex hormone-binding globulin and corticosteroid-binding globulin mRNAs in corpus luteum of human subjects. (1997) (9)
Plausible Linkage of Hypoxia-Inducible Factor (HIF) in Uterine Endometrial Cancers (2007) (9)
Scattering of the silver-stained proteins of nucleolar organizer regions in Ishikawa cells by actinomycin D. (1992) (9)
Expression of estrogen and progesterone receptors and their mRNAs in ovarian endometriosis. (1996) (9)
Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines. (2001) (9)
Expression of sex hormone-binding globulin mRNA in uterine cervical cancers. (1997) (9)
Antenatal subdural hemorrhage causing fetal death before labor (1993) (9)
PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells. (2006) (9)
Primary leiomyosarcoma arising from the greater omentum in a 15-year-old girl. (1999) (9)
[Normosmic idiopathic hypogonadotropic hypogonadism with GnRH receptor mutation(review)]. (2002) (9)
Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer. (2006) (9)
Placental growth by the estrogen-dependent angiogenic factors, vascular endothelial growth factor and basic fibroblast growth factor, throughout gestation (2004) (9)
Steroid Receptor mRNA Levels in Human Corpus luteum (1998) (9)
Dehydroepiandrosterone sulfate-binding sites in plasma membrane from human uterine cervical fibroblasts (1992) (9)
Clinical implication of medroxyprogesterone acetate against advanced ovarian carcinoma: a pilot study. (2008) (8)
Levels of Corticosteroid-Binding Globulin mRNA in Human Ovarian Cancers (1999) (8)
Successful outcome of pregnancy complicated with thyroidectomy-induced hypoparathyroidism and sudden dyspnea. A case report. (1993) (8)
Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment (2003) (8)
Hematosalpinx and torsion of the fallopian tube in a virgin girl. (1993) (8)
Effect of medroxyprogesterone acetate on sex hormone-binding globulin mRNA expression in the human endometrial cancer cell line Ishikawa. (1998) (8)
Expression of oestrogen receptor alpha and beta in uterine endometrial and ovarian cancers. (2002) (8)
In vitro and in vivo Antibacterial Activities of Telithromycin (2003) (8)
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell. (2004) (8)
Cavernous lymphangioma arising from uterine corpus. (2003) (8)
Progesterone receptor in human endometrium of leiomyoma uteri. (1977) (8)
Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen (1997) (8)
Effects of sex steroids on silver stained proteins of nucleolar organizer regions (Ag-NOR) in the rabbit uterus. (1998) (8)
Ability of Ovarian Steroids to Regulate the Expression of the Fibroblast Growth Factor Family in Fibroblasts Derived from Uterine Endometrium. (1996) (8)
Immunohistochemical expressions of estrogen and progesterone receptors in human epididymis at different ages--a preliminary study. (1997) (8)
Preterm labor and bacterial intra-amniotic infection: arachidonic acid liberation by phospholipase A2 of Prevotella bivia. (1998) (8)
Expression of corticosteroid-binding globulin mRNA in human uterine endometrial cancers (1995) (8)
Internal bacterial flora of solid uterine cervical cancer. (1993) (8)
Immunohistochemical study of estradiol, epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor in endometrial neoplasia. (1996) (7)
Effects of Crude Herbal Ingredients on Serum Levels of Inflammatory Cytokines in a Rat Uterine Endometritis Model (2000) (7)
Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells (2003) (7)
Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis. (2004) (7)
Therapeutic Effects of an Injectable New Quinolone, Pazufloxacin, against Polymicrobial Infections in the Uterine Endometritis Model (1998) (7)
Effects of danazol and medroxyprogesterone acetate on estrogen-(estradiol and estriol) specific binding sites in rabbit uterus. (1995) (7)
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections]. (2006) (7)
Relation between steroid receptor levels and prolactin level in the decidua of early human pregnancy. (1985) (7)
Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine myometrium and leiomyoma (1997) (7)
In vitro Activities of Pazufloxacin,a Novel In jectable Quinolone, against Bacteria Causing Infections in Obstetric and Gynecological Patients (1999) (7)
Effects of Estradiol and Testosterone on the Synthesis, Expression and Degradation of Androgen Receptor in Human Uterine Endometrial Fibroblasts. (1995) (7)
Augmentation of antiproliferative activity of CPT‐11, a new derivative of camptothecin, by tumor necrosis factor against proliferation of gynecologic tumor cell lines (1991) (7)
Direct action of gonadotropin-releasing hormone (LH-RH) analogue on ovary: an alternative acting mechanism of buserelin (2006) (7)
Lack of evidence for expression of Fas ligand in Fas-bearing tumors. (1998) (7)
Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase. (2002) (7)
Expression of E-cadherin, alpha- and beta-catenin mRNAs in ovarian endometriosis. (1996) (7)
Estrogen induces the expression of c-fos and c-jun genes in fibroblasts derived from human uterine endometrium. (2009) (7)
Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis (2003) (7)
In vitro Bactericidal Activities of Antimicrobial Agents and Morphologic Changes on Prevotella bivia (1999) (7)
Prognosis of cervical cancers with reference to steroid receptors. (1989) (6)
Treatment of recurrent gynaecologic malignancies with a new camptothecin derivative. (1992) (6)
Direct intraperitoneal insemination in ovarian hyperstimulation cycles induced with gonadotropin-releasing hormone agonist. (1997) (6)
Intra-amniotic Infection Caused by Capnocytophaga Species (1996) (6)
Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient (2003) (6)
Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells. (2005) (6)
Quantitative analysis of estrogen receptor proteins in rat ovary (2005) (6)
Leptin as an Acute Stress‐Related Hormone in the Fetoplacental Circulation (2002) (6)
Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections (2003) (6)
[Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae]. (2005) (6)
Nucleolar organizer regions in malignant transformation of uterine cervix. (1990) (6)
Successful outcomes of pregnancy complicated with dermatomyositis. Case reports. (1992) (6)
DNA polymorphism in B-domain of the estrogen receptor-alpha among Japanese women. (1998) (6)
Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation. (1989) (6)
Endometrial bacterial flora detected in patients with uterine endometrial cancer. (1993) (6)
Prolactin Binds to Human Endometrial Fibroblasts and Inhibits Mitogenicity of an Endometrial Carcinoma Extract (1993) (6)
Juvenile granulosa cell tumor in a 2-year-old infant: report of a case complicated with ascites and acute respiratory distress. (1992) (6)
Therapeutic effects of cefluprenam (CFLP) on polymicrobial infections associated with Enterococcus faecalis in rat pyometra model. (1997) (6)
Membrane-associated serine/threonine protein phosphatase in endometrial cancer. (2003) (6)
Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers. (2010) (6)
Expression of estrogen receptor β exon-deleted variant mRNAs in ovary and uterine endometrium (2003) (6)
Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative (1994) (6)
Silver-stained nucleolar organizer regions in the normal, hyperplastic and neoplastic endometrium (2005) (6)
Therapeutic effects of herbal medicines (Juzen-taiho-to and Ryutan-shakan-to) in a rat intrauterine infection (pyometra) model (1997) (6)
Adequate Macrolide Treatment Schedules for Uterine Cervicitis Caused by Chlamydia trachomatis (1999) (5)
Possible evidence that dehydroepiandrosterone sulfate (DHA-S) stimulates cervical ripening by a membrane-mediated process: specific binding-sites in plasma membrane from human uterine cervix. (1991) (5)
Introduction of p21(Waf1/Cip1) gene into a carcinoma cell line of the uterine cervix with inactivated p53. (1997) (5)
Evidence for tight coupling of phospholipase activation and Ca2+ influx during acrosome reaction of golden hamster spermatozoa. (1990) (5)
Second meiotic nondisjunction of the rearranged chromosome in a familial reciprocal 5/13 translocation. (1991) (5)
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. (2006) (5)
In vitro antibacterial activities of telithromycin, a new ketolide, against bacteria causing infections in obstetric and gynaecological patients. (2000) (5)
Phospholipase C in human endometrial fibroblasts and its regulation by estrogens. (1990) (5)
Characterization of growth-restricted fetuses with breakdown of the brain-sparing effect diagnosed by spectral Doppler. (2001) (5)
Evidence of a role for phosphatidylinositol synthesis in human amnion cell proliferation. (1992) (5)
Estradiol-17 beta-, progesterone and 5 alpha-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject. (1979) (5)
Pelvic abscess and fungemia caused byCandida glabrata (1996) (5)
Effects of selective estrogen receptor modulators and genistein on the expression of ERα/β and COX-1/2 in ovarectomized mouse uteri (2007) (5)
The use of pelvic peritoneum in the construction of a vagina: 10 cases. (2010) (5)
Expression of oestrogen receptor-a and -b in ovarian endometriomata (1999) (5)
Synergistic effects of interferon-gamma and tumor necrosis factor against proliferation of gynecologic tumor cell lines. (1989) (5)
Effects of estradiol-17 beta and estriol on their binding sites in the rabbit uterus. (1990) (5)
Possible mechanism for preterm labor associated with bacterial infection. II: Enhancement of endotoxin-stimulated phosphoinositide metabolism by sex steroids in human endometrial fibroblasts. (1990) (5)
Possible mechanism for preterm labor associated with bacterial infection. I: Stimulation of phosphoinositide metabolism by endotoxin in endometrial fibroblasts. (1990) (5)
Effects of selective estrogen receptor modulators and genistein on the expression of ERalpha/beta and COX-1/2 in ovarectomized mouse uteri. (2007) (5)
Preliminary study of oncogene expressions in endometrial cancers. Aberrant estrogen receptor gene and erbB-2 expressions. (1995) (5)
Differential efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment on pedunculated and degenerated myomas: a retrospective study of 630 women. (2000) (5)
Estriol binding in uterine corpus cancer and in normal uterine tissues. (1991) (5)
Postpartum microangiopathic hemolytic anemia: cases of successful and dismal outcome assisted with plasma therapy. (2000) (5)
RELATION BETWEEN STEROID RECEPTOR LEVELS AND PROLACTIN LEVEL IN THE ENDOMETRIAL STROMAL CELLS (1988) (5)
Preventive procedures against GBS infection by means of antibody measurement. (2000) (5)
Different patterns of p53 gene-mutations in endometrial carcinomas and endometrioid carcinomas of the ovary. (1994) (4)
Estrogenrelated receptor in reproductive organs (2005) (4)
Augmentation of antiproliferative activity of recombinant human tumor necrosis factor by delta 12-prostaglandin J2. (1990) (4)
Suppression of growth-promoting activity in extract from human uterine cancer by cyclic AMP-mediated mechanism. (1991) (4)
Silver-stained nucleolar organizer regions in the uterine myomatous tumors. (1996) (4)
Uterine contractions might increase heart preload in the recipient fetus in early‐onset twin–twin transfusion syndrome: an ultrasound assessment (2004) (4)
Induction of M-CSF Receptor and its mRNA, and Activation of Tyrosine Kinase in Peripheral Monocytes by Oestradiol-17β and Progesterone (1995) (4)
Soybean isoflavones inhibit estrogen-stimulated gene expression in mouse uteri. (2004) (4)
Effects of long-term administration of roxithromycin on neutrophil count and interleukin-8 level in endometrial cavity subjected to pyometra. (1997) (4)
Oestrogen Induces C-Ha-Ras Expression in the Fibroblasts Derived from Human Uterine Endometrium (1995) (4)
Penetration of oral telithromycin into female genital tissues (2003) (4)
In vitro and in vivo Antibacterial Activities of AM-1155 in the Fields of Obstetrics and Gynecology (1998) (4)
Incomplete Testicular Feminization Syndrome: Studies of 17β-Oestradiol-Binding Activity and Aromatase Activity in Cultured Genital Fibroblasts Showing Impaired Dihydrotestosterone-Binding (1992) (4)
Prolactin Binds to Human Endometrial Fibroblasts and Inhibits Mitogenicity of an Endometrial Carcinoma Extract (1993) (4)
Detection of SRY in a 46,XY female (Swyer's syndrome). (1997) (4)
Bacterial flora detected in the uterine endometrial cavity of normal puerperae on the puerperal first day and on the puerperal fifth day after incidental use of cefpodoxime proxetil. (1993) (4)
Preliminary Studies on Steroid-Binding Proteins in Human Testes of Testicular Feminization Syndrome (1978) (4)
In vitro Bactericidal Activities of a New Oral Cephalosporin, E1100, and Morphologic Changes on Escherichia coli (1999) (4)
The biologic role of sex steroid receptors in the decidualization of human endometrium. (1985) (4)
Preterm labor and bacterial intra-amniotic infection: Arachidonic acid liberation by the action of phospholipase A2 (2004) (4)
Effect of cefotaxime on blood coagulation (1988) (4)
Steroid receptors and metastatic potential in endometrial cancers. (2000) (4)
Chromosome abnormalities associated with recurrent abortion. (1996) (3)
Effects of ipriflavone and estriol on postmenopausal osteoporotic changes (1995) (3)
Sex hormone-binding globulin and corticosteroid-binding globulin mRNA levels in infertile women with luteal phase deficiency. (1995) (3)
Ovarian squamous cell carcinoma derived from a dermoid cyst presenting as vaginal metastasis and the implication of its steroid receptor levels--two case reports. (1986) (3)
Comparison of tritium-labeled steroids for progesterone receptor assay in human endometrium. (2010) (3)
Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers (1999) (3)
Detection of inguinal endometriosis by magnetic resonance imaging (MRI) (1994) (3)
Study on treatment of bacterial vaginosis with oral administration of metronidazole or cefdinir. (1994) (3)
Occurrences of estrogen and progestin receptors and nuclear binding of steroid-receptor complex in human endometrial cancer. (2010) (3)
Drug Concentrations in the Pelvic Retroperitoneal Space Exudate after the Combined Administration of Cephems and Amikacin (1992) (3)
Effects of Long-Term/Low-Dose Clarithromycin on Neutrophil Count and Interleukin-8 Level in Pyometra (1997) (3)
Pharmacokinetics of miconazole in serum and exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy. (1997) (3)
Primary brain malignant lymphoma newly diagnosed during pregnancy. (1995) (3)
Pseudomyxoma peritonei and mucinous pyometral fluid arising from an ovarian borderline mucinous tumor: case report. (2007) (3)
Huge intraabdominal fibromatosis on the posterior wall of uterus: a case report. (1986) (3)
Comparative study on expression of plasminogen activator inhibitor 1 and its mRNA in endometrial cancers and normal endometria. (1997) (3)
Prognostic implications of cimetidine on advanced serous ovarian carcinoma related to cyclooxygenase-2 expression. (2008) (3)
In vitro Bactericidal Activitiesand Morphologic Changes in Escherichia coli and Bacteroides fragilis by Cephalosporins (1998) (3)
A good outcome pregnancy in a patient with paroxysmal nocturnal hemoglobinuria. (1989) (3)
Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation. (2003) (3)
Progestin Regulation in Tumor Growth of Female Genital Tract Cancers (1999) (3)
Pharmacokinetics of Fluconazole in the Serum and Exudate of the Pelvic Retroperitoneal Space after Radical Hysterectomy and Pelvic Lymphadenectomy (1995) (3)
[Pharmacokinetic and clinical studies on aztreonam in the perinatal period]. (1990) (3)
In vitro Activities of E1101, a Novel Oral Cephalosporin, against Bacteria Causing Infections in Obstetric and Gynecological Patients (1998) (3)
Changes in the number of silver-stained nucleolar organizer regions in the normal, preneoplastic, and neoplastic endometrium. (1995) (3)
Steroid receptors in uterine cervical cancers. (1986) (3)
Characterization of growth-restricted fetuses with breakdown of the brain-sparing effect diagnosed by spectral Doppler (2001) (3)
Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation. (2010) (3)
[Intravaginal bacterial flora in patients with uterine cervical cancer, with special reference to Gardnerella vaginalis]. (1990) (3)
Effects of dioxin and nutrition on cellular proliferation and dioxin- and estrogen-linked genes in ovarian cancer cell lines. (2005) (3)
Effects of Juzen-taiho-to and M-CSF on Thrombocytopenia induced by Anti-cancer Drugs in Gynecologic Malignancies. (2000) (2)
Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum. (1996) (2)
Direct interaction between human endometrial carcinoma and fibroblast: fibroblast-derived growth factor. (1991) (2)
Alteration of GTP-binding proteins in ovarian tumors (Review). (1996) (2)
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. (1998) (2)
Sensitivity of polymerase chain reaction to determine chlamydia trachomatis eradication rate with levofloxacin therapy in patients with chlamydial cervicitis. (2003) (2)
Chromatin transcription by progesterone-receptor complex in rabbit uterus. (1979) (2)
Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells. (2002) (2)
Estradiol stimulation of inositolphospholipid metabolism in human endometrial fibroblasts. (1989) (2)
Ureteral obstruction caused by intrinsic ureteral endometriosis with adenomyosis but without pelvic endometriosis. (1995) (2)
In vitro antibacterial activity of FK037, a new parenteral broad-spectrum cephalosporin, against recent clinical isolates in the fields of obstetrics and gynecology. (1994) (2)
[Pharmacokinetic and clinical studies on flomoxef in perinatal period]. (1991) (2)
Estrogen and progestin inhibit invasiveness of gynecologic metastatic cancer cells to blood vessel endothelium. (1998) (2)
Expression of Fas in female reproductive tract tumors. (1996) (2)
Prolactin receptor-linked tyrosine-phosphorylation of membrane-proteins is mediated by GTP-binding protein in endometrial carcinoma and endometrium. (1994) (2)
Prenatal diagnosis of peroxisome biogenesis disorders by means of immunofluorescence staining of cultured chorionic villous cells (1999) (2)
Inhibition by Prolactin of Membrane-Associated Phosphatidylinositol Kinase of Human Endometrial Fibroblast (1994) (2)
Penetration of Fluconazole into Gynaecological Tissues (1995) (2)
[Effectiveness of switch therapy for peritonitis]. (2007) (2)
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate (2008) (2)
Massive ovarian serous cystadenoma with uneventful postoperative recovery. (1991) (2)
Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus. (1991) (2)
Juvenile fulminant adnexal tuberculosis caused by gastrointestinal tuberculosis immediately after ovarian cystectomy (2000) (2)
Treatment of pelvic endometriosis with gestrinone--report on 9 cases. (2010) (2)
Cancers as a Novel Predictor of Advancement of Uterine Cervical The Value of Platelet-derived Endothelial Cell Growth Factor Updated (2000) (2)
Enhanced magnetic resonance imaging evaluation for spread of cervical carcinoma (1993) (2)
Silver-stained nucleolar organizer regions in adenocarcinoma of the cervix--a light and electron microscopic study. (1997) (2)
Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses (2000) (2)
Novel therapeutic strategy for uterine arteriovenous fistulas: case report. (2010) (2)
Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4 (1991) (2)
Decrease in interferon-gamma production by peripheral blood mononuclear cells in patients with uterine cervical cancer. (1990) (2)
FERTILITY PRESERVATION IN THE MANAGEMENT OF UTERINE CERVICAL CANCERS (2003) (2)
Therapeutic Effects of Cefozopran on Polymicrobial Infections Associated with Enterococcus faecalis in a Rat Pyometra Model (1998) (1)
Studies on Progesterone Receptor^|^hellip;Determination and Stability of 8S Macromolecule^|^hellip; (1976) (1)
Effects of Japanese Kampo Medicine on Climacteric Syndrome (1994) (1)
Changes in the prolactin response to thyrotropin-releasing hormone (TRH) throughout the proliferative phases in the ovulatory and anovulatory menstrual cycle. (1991) (1)
Successful pregnancy in a patient with heart failure secondary to aortic and mitral regurgitation. (1993) (1)
Pericentric inversion of chromosome 7 associated with recurrent abortion (1996) (1)
In-vitro activity of S-1090, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynaecological patients. (1998) (1)
Ultrasonically guided follicular aspiration during a pregnancy with massive ovarian cysts following ovulation induction by gonadotropins. (1993) (1)
Primary lymphoma of the uterine corpus: an unusual location for a common disease--case report. (2007) (1)
Steroid Specificity of Progestogen Receptor in Rabbit Uterus (1974) (1)
Invasion and metastasis of gynecological cancers with reference to endocrine milieu (1996) (1)
Adenoid cystic carcinoma of the cervix: a report and review of 3 cases. (2010) (1)
Sex steroids enhance endotoxin-stimulated phospholipase A2 activity in hum endometrial cells (2006) (1)
[The mechanism of the action of progesterone--the effects of estrogen priming on the nucleus (author's transl)]. (1977) (1)
In vitro and in vivo Antibacterial Activities of a New Carbapenem BO-2727 for Use in Obstetrics and Gynecology (1997) (1)
Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell. (2004) (1)
Estrogen and progestogen receptor levels in different types of mid-secretory endometrium. (2010) (1)
Antimicrobial susceptibility and pharmacokinetics of doripenem in the field of obstetrics and gynecology (2005) (1)
Steroid binding macromolecules in ovaries and parovarian cysts in human subjects. (2010) (1)
[Clinical investigation on administration method of gatifloxacin based on PK/PD theory]. (2006) (1)
Gonadotropin-releasing-hormone (gn-rh) receptor in the reproductive-tract tumor - physiological-role and signal-transduction pathway. (1995) (1)
The failed suppression of serum estradiol level by gonadotropin-releasing hormone agonist in a case of pelvic endometriosis. (1998) (1)
Endocrine features in eutestosteronemic women with polycystic ovaries. (1994) (1)
GTP-binding protein and its associated event in membranes from endometrial carcinoma. (1996) (1)
A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient. (1998) (1)
A putative growth factor in extract from uterine cancers. (1989) (1)
Pregnancy during postoperative management of virilising arrhenoblastoma. (1999) (1)
[Danazol--up-to-date aspect for endometriosis]. (2001) (1)
[Interaction of norethindrone on estrogen and progesterone receptors in the rabbit uterine cytosol (author's transl)]. (1975) (1)
Antenatal evaluation of upper gastrointestinal dilatation complicated by non-immune hydrops fetalis and polyhydramnios. (1989) (1)
In vitro bactericidal activity and morphologic change in Bacteroides fragilis and Prevotella bivia with azithromycin (2000) (1)
Postoperative vesicourethral function after ultrasonic surgical aspirator-assisted surgery of gynecologic malignancies. (2000) (1)
Aberrant adnexal blood supply (1994) (1)
Bacterial flora detected of the uterine endometrial cavity of diabetic patients with myoma uteri. (1993) (1)
Extra marker chromosome, dic(22)(q11), associated with gonadal dysgenesis and multiple malformations (1994) (1)
Bacterial flora in the uterine endometrial cavity of healthy subjects on the first and fifth days of the puerperium (1998) (1)
Nuclear translocation of progesterone receptor--progestogen complex in vitro. (1983) (1)
[Incidence of Mobiluncus spp. from the patients with clinical bacterial vaginosis]. (1992) (1)
[Investigation on administration method of carbapenems]. (2002) (1)
Regulation by calcium-ion of choriocarcinoma aromatase-activity. (1995) (1)
Nuclear steroid receptors in endometrial cancers. (2010) (1)
[Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy]. (1998) (1)
NM441: Penetration into Gynaecological Tissues and In Vitro Activity against Clinical Isolates from Obstetric and Gynaecological Patients (2012) (1)
[Estrogen receptors in meningiomas and neurinomas (author's transl)]. (1982) (1)
[Progestogen receptor in the uterus of rabbits and rats]. (1973) (1)
Recurrent abortion associated with 1qh+. (1995) (1)
Difference of progesterone and related compounds in activation of progesterone receptor (PR) in the rabbit uterus (1986) (1)
In vitro and in vivo antibacterial activity of E1010, a new injectable carbapenem (2001) (1)
Evidence for common signalling pathways of GnRH receptor and Fas in tumors. (1996) (1)
Fetal blood sampling in the assessment of acute nonimmune hydrops fetalis. (1995) (1)
Expression of ETS-1 Related to Angiogenesis in Uterine Endometrium during the Menstrual Cycle (2003) (1)
Relatively High Expression Ratio of Sex Hormone‐binding Globulin Exon VII Splicing Variant to Wild‐type mRNA in Human Uterine Cervical Cancers (1998) (1)
In vitro and in vivo Antibacterial Activities of S-1090, a New Oral Cephalosporin, in the Fields of Obstetrics and Gynecology (1998) (1)
Progestogen Receptor in the Rabbit and Rat Uterus (1973) (0)
87 Analysis of antiproliferative activity of recombinant human tumor necrosis factor by Δ^ -prostaglandin J_2 on gynecologic tumor cell lines. (1990) (0)
310. Induction of Cytokines in Ascites of Patients with Ovarian Cancer by OK-432 (1988) (0)
Steroid hormone responsiveness of stroma in endometrial cancer tissue (1987) (0)
[Clinical efficacy of cefpirome sulfate against Bacteroides species, Prevotella species and Porphyromonas species. Society of Anaerobic Bacterial Infections in the fields of obstetrics and gynecology in Gifu]. (2000) (0)
205. Histochemical Observation of Nucleolar Organizer Regions in Endometrial Carcinoma (1988) (0)
Pivmecillinam in treatment of complicated urinary tract infections during initial prophylactic therapy after radical hysterectomy. (2010) (0)
42. Sex Steroid Receptors in Normal Myometrium and Benign Uterine Tumor of Human Subjects (1978) (0)
Endometriosis and various pelvic lesions associated with hyperprolactinemia. (2010) (0)
Phospholipase C activity in human placental membrane (2004) (0)
Antibacterial Activity of Gatifloxacin in Obstetrics and Gynaecology (1999) (0)
Studies on the standardization of uterine cervical smears using a high-quality image analytical system. (1990) (0)
In vitro and in vivo Antibacterial Activities of Biapenem in the Fields of Obstetrics and Gynecology (2000) (0)
222 Effect of danazol to the estrogen binding sites of peripheral blood monocytes. (1990) (0)
Norethindrone scatters silver-stained nucleolar organizer regions of Ishikawa cells. (1991) (0)
Infection Caused by Capnocytophaga Species (1997) (0)
Uterine bacterial flora on the first and fifth postpuerperal days after continuous, open-label, uncontrolled cefditoren dosing (1997) (0)
Discrepancy of endometrial dating in mid-luteal phase of hyperprolactinemic women. (2010) (0)
[Fundamental and clinical evaluation of cefodizime in obstetrics and gynecology]. (1989) (0)
IS-31 Decrease in G Protein Coupling to phosphatidylinositol Kinase Stimulation in Pregnant Myometrium (1997) (0)
[Progesterone and reproductive biology]. (2006) (0)
287 Control of the synthesis of specific binding sites in estradiol-17 Beta and estriol by the ejection of estradiol and the relation with anti-estrogen effect. (1989) (0)
IS-18 A GnRH-responsive Phosphatase Hydrolyses LPA within the Plasma Membrane of Ovarian Cancer Cells (2001) (0)
[Study on the therapeutic effect of panipenem/betamipron on perinatal infection in pregnant women]. (1999) (0)
In vivo bacterial regrowth-inhibition effect of cefbuperazone and amikacin in puerperal uterine cavity. (1995) (0)
Book Review / Erratum (1994) (0)
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. (2000) (0)
Prophylactic Use of Antibiotics and Closing of the Vaginal Cuff against Pelvic Retroperitoneal Infection after Radical Hysterectomy with Pelvic Lymphadenectomy (1991) (0)
33.Relation of Myoma Growth and Steroid Receptor Mechanism : VI Phisiology and Pathology of Sexual Organs(I) (1983) (0)
Basic and clinical studies on FK037 in obstetrics and gynecology (1994) (0)
20 – Role of Immunohistochemical Expression of ETS-1 Factor in Ovarian Carcinoma (2006) (0)
Inhibitory Effects of Phytoestrogens and Related Herbal Extracts on Mouse Endometrial Carcinogenesis: A Review (2003) (0)
87 Steroid hormone recognition mechanism in human endometrial fibroblasts : Transmembrane signalling. (1989) (0)
These results indicate that the function of estrogen priming on the mechanism of action of progesterone is the synthesis of progesterone-receptor and the increase of non- specific binding sites of progesterone•macromolecule (non-specific binding protein) in the nucleus (2012) (0)
221 Concentrations of interleukin 1 (IL-1), tumor necrosis factor (TNF), and interferon (IFN-γ) in peritoneal fluid, and production of IL-1 and TNF by peritoneal macrophages from patients with or without endometriosis. (1990) (0)
BASIC AND CLINICAL STUDIES ON CEFPIROME IN OBSTETRIC AND GYNECOLOGICAL INFECTIONS (1991) (0)
15 Inhibitory effects of estradiol on growth-promoting activity in human uterine cancer extracts. (1990) (0)
[Effects of levofloxacin once-a-day therapy on uterine cervicitis]. (1999) (0)
187. Steroid Receptors and Tumor Associated Substances in Ovarian Tumors (1982) (0)
104 Depression of Interferon-γ Production by Peripheral Blood Mononuclear Cells in Cervical Cancers. (1989) (0)
379. Preterm Labor and Arachidonic Acid Liberation: Stimulation of Endometrial Phospholipase A_2 by Bacterial Product (1988) (0)
In Vitro Bactericidal Activity and Morphologic Change in with Azithromycin (2000) (0)
Sex Steroid-Dependent and -Independent Angiogenesis in Uterine Endometrial Cancers (2003) (0)
Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432. (1988) (0)
143. Characteristics of Partially Purified Cytoplasmic Progesterone Receptor in Rabbit Uterus (1977) (0)
90 Silver-stained nucleolar organizer regions (AgNORs) in the normal menstrual cycle using by cytlogical materials. (1991) (0)
Subject Index Vol. 66, 2004 (2004) (0)
Contents Vol. 49, 2000 (2000) (0)
Studies on Biological Implication of Gonadotropin-releasing Hormone (Gn-RH) and its Receptor in Human Ovarian Carcinoma (1994) (0)
Clinical implication of hyperprolactinemias, especially with prolactinoma and luteal insufficiency. (2010) (0)
[A fundamental study of copper-T (intrauterine device)]. (1978) (0)
Successful treatment by danazol of a patient with anorexia nervosa (1993) (0)
73. Production of Interferon-gamma in Peripheral Mononuclear Cell of Patients with Gynecologic Cancer and Regulation Mechanism of Interferon-gamma (1988) (0)
Phosphatidylinositol kinase activity in ovarian cancer cells. (2001) (0)
Preventive Effects of Indole-3-carbinol on Endometrial Carcinogenesis in Mice (2004) (0)
Contents Vol. 58, 2000 (2000) (0)
Author and Subject Index (1999) (0)
222. Steroid Receptors of Human Uterine Endometrium in Luteal Phase (1982) (0)
295 Immunohistochemical studies on epidermal growth factor (EGF), transforming growth factor-α (TGF-α) and EGF receptor (EGF-R) in carcinoma of the uterine cervix and ovarian tumor. (1989) (0)
1. Gynecological Tumor and Steroid Receptor : The Relationship between Endocrine Hormone and Gynecologic Tumors : Experimental and Clinical Studies (1983) (0)
267 Estrogen Binding Sites (E2R and E3R) in Cardiovascular System of rabbit. (1991) (0)
[The effect of metallic ions on steroid hormone receptors in the rabbit uterus (author's transl)]. (1975) (0)
Implications of subcellular steroid binding sites in endometrial cancer, determined by an immunofluorescent steroid-antibody technique and biochemical assay. (1984) (0)
Possible evidence for estrone-specific binding sites in human uterine endometrial carcinoma. (1994) (0)
Autocrine and Paracrine Actions of Prolactin in Uterine Neoplasia (2020) (0)
[The interaction of progestogens of the estrane series with progesterone receptor in rabbit uterine cytosol (author's transl)]. (1977) (0)
19. Steroid Hormone Receptors in Human Uterine Adenocarcinomas (1977) (0)
Changes of silver-stained nucleolar organizer regions in mouse endometrial carcinogenesis induced byN-methyl-N-nitrosourea and 17β-oestradiol (2005) (0)
[Clinical evaluation of pivmecillinam in the maintenance therapy of chronic urinary tract infection (author's transl)]. (1981) (0)
Cellular existence of estrogen receptor in C3H mouse mammary tumor. (1986) (0)
[Endocrine functional ovarian tumor]. (2006) (0)
100. Response Indicator of Chemo-endocrine Therapy for Endometrial Cancer by Colony-forming Assay : (1986) (0)
A Case of Toxemia of Pregnancy Treated with Kampo Formula Syakuyaku-kanzou-tou for Plausible Inhibition of Autoimmune Antibody (1996) (0)
Overexpression of C-erbb-2 protein in endometrial carcinoma is associated with advanced-stage disease. (1994) (0)
Figo clinical stage IIb carcinoma of the uterine cervix and surgical staging. (1994) (0)
[Fundamental and clinical evaluation of imipenem/cilastatin sodium in the perinatal period]. (1988) (0)
252 Growth factors stimulasted by estradiol in endometrial neoplastic lesions. (1989) (0)
[Effect of preoperative oral 5-fluorouracil on cell cycle of advanced cervical squamous cell carcinoma]. (1996) (0)
Local progestational and antiprogestational effects of steroids and their metabolites on the rabbit uterus. (1979) (0)
Steroid receptor levels in ovarian endometrial cysts and their cultured fibroblasts (1988) (0)
The influence of bile on antimicrobial activity in vitro (1998) (0)
Drug concentrations in the pelvic retroperitoneal space exudate after the combined administration of cephems and astromicin (1994) (0)
[Proceedings: Follicle hormone activity of norethindrone in the hypothalamic nucleus]. (1974) (0)
Psychosomatic disorder in female life cycle : in relation of sex steroids (2006) (0)
Contents, Vol. 37, 1994 (1991) (0)
32 Silver-stained nucleolar organizer regions in gynecologic neoplasms and its clinical implication. : (1991) (0)
87. Relation between Steroid Receptor Levels and Prolactin Level by Human Endometrial Stroma Cell in Sectretory Phase (1985) (0)
[Epidemiology of ovarian cancer]. (2004) (0)
20 Nucleoar organizer regions (NORs) in the neoplastic and preneoplastic lesions in the hunam endometrium. (1990) (0)
[A questionnaire survey on the theory of postoperative infection prophylaxis in gynecology]. (2001) (0)
Kallmann syndrome in females: gonadotropin versus GnRH to induce fertility. (1996) (0)
The effects of fibroblasts on the steroid responsiveness of the endometrial cancer cells (hashimoto) in the thymidine uptake (1987) (0)
Alternative gonadotropin-releasing hormone processing products secreted from endometrial carcinoma. (2000) (0)
[The review of the treatment of the carcinoma of the uterine cervix in Gifu University Hospital. Primary treated cases from 1972 to 1982]. (1989) (0)
[Cellular biology of sex steroid and clinical implication]. (1993) (0)
[Effects of sex steroid hormones on renal functions in molecular biology]. (2006) (0)
Interaction of interferon gamma and CPT-11, a new derivative of camptothecin, in human endometrial carcinoma cell lines (1992) (0)
[Gynecologic tumors and steroid receptors]. (1983) (0)
Ultrasound-detected polycystic ovarian syndrome associated with depleted basal level but enhanced response of gonadotropin. (1995) (0)
Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: Inhibition by plant herb extracts of steroid protein binding in the rabbit (1987) (0)
Basic and Clinical Studies of Levofloxacin in Obstetrics and Gynaecology (1993) (0)
[The effect of enzymes on progesterone-receptor binding and chromatin binding of the complex in the estrogen-primed rabbit uterus (author's transl)]. (1978) (0)
[Phospholipid metabolism in ovarian function]. (1991) (0)
The effects of the extension of transit times on qualitative and quantitative bacterial culture after clinical sampling. (1999) (0)
IS-48 Coupling of 35-kDa Protein Dephosphorylation to Gonadotropin-Releasing Hormone Receptor in Ovarian Carcinoma Membrane (1996) (0)
[Pharmacokinetic and clinical studies of ceftizoxime in obstetrical and gynecological field (2)]. (1988) (0)
Studies on Effects of Estrogens on Gynecological Tumor Proliferation : Aromatase (P450arom) Expression in Epithelial Carcinoma and Stromal Cells of Human Ovary and Their Interaction (1994) (0)
IS-28 Association of PTEN with Drug-Induced Apoptosis in Endometrial Carcinoma Cells (2001) (0)
Contents, Vol. 15, 1994 (1994) (0)
138 The Role of tumor necrosis factor in the cascade of T-lymphocytes and monocytes in gynecological cancer patients. (1989) (0)
211. Studies on Steroid Hormone Receptor in Ovarian Tumors (1981) (0)
Subject Index Vol. 49, 2000 (2000) (0)
14 Synergistic enhancement of growth-promoting activity in extract from uterine cancers by phorbol ester and diacylglycerol through activation of protein kinase C in endometrial fibroblasts. : (1991) (0)
527 Platelet count and platelet-associated IgG level in maternal and cord bloods complicated with or without idiopathic thrombocytopenic purpura. (1990) (0)
15th International Symposium and 20th Annual Meeting of Japan Human Cell Society (2011) (0)
COMPARATIVE STUDY OF IN VITRO ACTIVITY OF NM394 AND FOUR OTHER NEW QUINOLONES AGAINST CLINICAL ISOLATES FROM PATIENTS WITH OBSTETRIC AND GYNECOLOGIC INFECTIONS (1996) (0)
Inhibition of bacterial regrowth in the puerperal uterine cavity of flomoxef (1995) (0)
165. Clinical Implication of Steroid Receptor in Human Placenta (1984) (0)
311. Antiproliferative Effects of Human Recombinant Tumor Necrosis Factor on Gynecologic Tumor Cell Lines in vitro (Combined Effect with Interferons or Anticancer Drugs) (1988) (0)
Preliminary studies on streoid-binding proteins in human testes of testicular feminization syndrome. (1978) (0)
Steroid hormone receptor: the effect of metallic ions on steroid hormone receptors in the rabbit uterus. (1975) (0)
A-25 Evaluation of Antenatal Diagnosis of Fetal Intracranial Anomalies : Comparison between Magnetic Resonance Imaging and Ultrasonography. (1998) (0)
Therapeutic Effects of Sitafloxacin in Rat Uterine Endometritis (1999) (0)
Anti-estrogenic effect of androgen (1987) (0)
57 Effects of sex steroid on cellular immunity : cytokine production and proliferation of peripheral blood mononuclear cells (PBMCs). (1990) (0)
34.Estrogen Binding Sites in Human Endometrial Cancer : VI Phisiology and Pathology of Sexual Organs(I) (1983) (0)
Production of interferon γ by peripheral blood mononuclear cells in patients with uterine cervical cancer (1988) (0)
Biological Implicationsof Sex-Steroid-Modulated Oncogenes and Associated Genes in Uterine Normaland MalignatEndometria (1996) (0)
Usefulness and clinical implications of endometrial cytology during the conservative therapy for early endometrial carcinoma in the young woman (2005) (0)
Massive dermoid cyst of the ovary: magnetic resonance imaging evaluation with ultrasonography and computed tomography correlations (1993) (0)
IS-5 Cell growth suppression by PTEN gene introduction in Ishikawa cells (2000) (0)
[Effect of Copper-IUD on the human endometrium (author's transl)]. (1978) (0)
350 Specific action of norethisterone on nucleolar organizer regions in endometrial carcinoma cells. (1990) (0)
Bacterial Regrowth-Inhibition Effect of Cefmetazole and Netilmicin in the Puerperal Uterine Cavity (1993) (0)
171. Antitumoral Activities of Tamoxifen and Medroxyprogeserone Actate in Colony-forming Assay and Steroid Receptor Levels in Endometrial Cancers (1985) (0)
Studies on progesterone receptor in rabbit uterus. (1978) (0)
Contents Vol. 66, 2004 (2004) (0)
[Estrogen and reproductive biology]. (2006) (0)
Ovarian Abscess Caused by Peptostreptococcus magnusFollowing Transvaginal Ultrasound-GuidedAspiration of Ovarian Endometrioma and FixationWith Pure Ethanol (1998) (0)
Subject Index Vol. 15, 1994 (1994) (0)
166. Relation between Steroid Receptor Level and Prolactin Level in Human Uterine Decidua (1984) (0)
[Proceedings: Progesterone receptor in the rabbit uterus--with special reference to the transport progestogen into the nucleus]. (1974) (0)
Possibility of anti-estrogen action from estriol specific binding sites in rabbit uterus. (1990) (0)
[Adhesion molecules and immunological disorders]. (1991) (0)
76. Studies on the Testosterone Binding Globulin Human Serum (1980) (0)
Contents, Vol. 32, 1991 (1981) (0)
[A fundamental study of Copper-T (intrauterine device). Part 1 (author's transl)]. (1978) (0)
[Studies on progesterone receptor in rabbit uterine cytosol -- nuclear translocation and chromatin binding-- (author's transl)]. (1975) (0)
Cloning and partial sequencing of a novel human activin receptor-like kinase. (1997) (0)
[Inherited corticosteroid-binding globulin (CBG) deficiency]. (2006) (0)
Effects of danazol and progesterone on sex hormone-binding globulin mRNA expression in human endometrial cancer cell line Ishikawa (1997) (0)
Evaluation of placenta by magnetic resonance imaging (1998) (0)
Steroid receptors and histological types in cervical cancer. (2010) (0)
Unusual premature ovarian failure with hypogonadotropic hyperprolactinemia and 46, XX, 13ph+. (1999) (0)
236. Change of the Receptor Binding and the Biological Effect under Estriol Injection (1988) (0)
[Pathophysiology of Gn-RH receptor]. (1997) (0)
13. Estrogen-receptor Complex-dependent RNA Synthesis and the Effect of Anti-estrogens on RNA Synthesis (1979) (0)
Receptors--rationales of steroid therapy for pelvic endometriosis. (1987) (0)
Subject Index Vol. 58, 2000 (2000) (0)
Nucleolar organizer regions in malignant transformation of uterine cervix (1991) (0)
142. E_2 (Estradiol 17-β) in Luteal Function (1977) (0)
Erratum to “Nucleolar organizer regions in malignant transformation of uterine cervix” [Gynecol. Oncol. 39 (1990) 309–313] (2004) (0)
Inhibition of bacterial regrowth in the puerperal uterine cavity by cefbuperazone (1994) (0)
208. Binding of Estradiol to Purified Uterine Plasma Membranes (1981) (0)
Expression of cytokine genes in peritoneal macrophages from patients with pelvic endometriosis. (1993) (0)
47. Placental Membrane: Calcium Ion and Phosphoinositide Metabolism (1988) (0)
475 Estrogen receptors in brain tumors (1983) (0)
Phosphotyrosine phosphatase activity in ovarian carcinoma cells : stimulation by GnRH in plasma membrane. (2001) (0)
Effect of pregnancy on autoimmune disease (1996) (0)
243 Evidence for tight coupling of gonadotropin-releasing hormone receptor occupancy to stimulated phosphoinositide turnover and anti-gonado- tropin action in granulosa cells . (1991) (0)
Endometriosis associated with hyperprolactinaemia (1984) (0)
Magnetic resonance evaluation of uterine malformation with corpus agenesis. (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Teruhiko Tamaya?

Teruhiko Tamaya is affiliated with the following schools:

Gifu University

Teruhiko Tamaya's Academic­Influence.com Rankings

Teruhiko Tamaya's Degrees

Why Is Teruhiko Tamaya Influential?

Teruhiko Tamaya's Published Works

Published Works

What Schools Are Affiliated With Teruhiko Tamaya?

Teruhiko Tamaya's AcademicInfluence.com Rankings